The use of tacrolimus in renal transplantation

World Journal of Urology

Volumn 14, Issue 4, 1996, Pages 239-242

  Jordan, M L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; METHODOLOGY; PEDIATRICS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SALVAGE THERAPY;

GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PEDIATRICS; RANDOMIZED CONTROLLED TRIALS; SALVAGE THERAPY; TACROLIMUS;

EID: 0030332820     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00182074     Document Type: Article

References (12)

1. Ellis E. Shupiro R, Jordan ML. Scanllebury VP. Gilhoa N, Hopp L. Weichler N, Tzakis A, Simmons RL (1994) Comparison of FK 506 and cyclosporinc regimens in pédiatrie renal transplantation. Pediatr Nephrol 8: 193-200
2. Griffith BP. Bando K, Hardesty RL. Armitage JM, Keenan RJ, Pliam SM, Paradis IL. Yousem SA. Komatsu K, Konishi H. Fung JJ. Starzl TE (1994) A prospeetive randomized trial of FK 506 versus cyclosporine after human pulmonary transplantation. Transplantation 57:848-851
3. Jordan ML. Shapiro R, Vivas CA, Scantlebury VP. Darras HS. Carrier! G, McCauley J, Demetris AJ, Randhawa P. Jensen C. Hakala TR, Fung J. Starzl TE (1993) FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. Transplant Proc 25:638-640
4. Jordan ML, Shapiro R, Vivas CA. Scantlebury VP. Randhawa P. Carrier! G. McCauley J, Demetris AJ. T/akis A. Fung JJ, Simmons RL. Hakala TR. Starzl TE (1994) FK 506 -rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 57:860-865
5. Nishiyama M Izumi S, Okuhara M (1995) Discovery and development of FK 506 (tacrolimus). a potent immunosuppressant of microbial origin. In: Merluzzi VJ. Adams J (ed) The search for anti-inflammatory drugs. Birkhauscr, Boston, pp 65104
6. Shapiro R. Jordan ML, Scantlebury VP. Fung J. Sensen CWB. Tzakis A. Carroll P. McCauley J. Ricordi C. Mitchell S. Day R. Jain A. Iwaki Y. Reyes J. Todo S. Hakala TR. Simmons RL. Starzl TE (1991) FK 506 in clinical kidney transplantation. Transplant Proc 23:3065-3067
7. Shapiro R. Jordan ML. Scantelbury VP, Vivas C. Fung JJ. McCauley J. Randhawa P. Demetris AJ. Irish W, Mhchell S. Hakala TR. Simmons RL. Starzl TE ( 1995) A prospecitve ran-domized trial of FK-506 bused immunsuppression after renal transplantation. Transplanuition 59:485-490
8. Shapiro R. Jordan ML. Scantlebury VP, Vivas C. Fung JJ, McCauley J, Randhawa P. Demetris ÄJ, Irish W. Jain A, Mitehell S. Hakala TR, Simmons RL. Star/1 TE (1995) A prospective randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc 27:814-817
9. Shapiro R. Scantlebury VP, Jordan ML. Vivas C. Tzakis AG. Ellis D. Gilboa N, Hipp L. McCauley J, Irish W. Mitehell S. Hakala TR. Simmons RL. Starzl TE'(1995) FK 506 in pédiatrie kidney transplantation - primary and rescue experience. PediatrNephrol 9:843-848
10. Star/l T, Todo S. Fung J. Demetris AJ. Veiikataraman R. Juin A (1989) FK 506 for liver, kidney and pancreas transplantation. Lancet II: 1000-1004
11. Todo S, Fung JJ. Demetris AJ. Jain A. Venkalaranianou R, StarJ.l TE ( 1990) Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc 22: 13-16
12. Todo S, TJ.akis A. Reyes J. Abu-Elmagcl K, Furukawa H, Nour B. Casavilla A. Nakamura K, Fung J. Demetris AJ. Star/I TE ( 1994) Small intestinal transplantation in humans with or without the colon. Transplantation 57:840-848